Jack Cuzick

About Jack Cuzick

Jack Cuzick, With an exceptional h-index of 158 and a recent h-index of 88 (since 2020), a distinguished researcher at Queen Mary University of London, specializes in the field of cancer prevention.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract PS10-03: Impact of Baseline Oestradiol and Testosterone on the Preventive Effect of Anastrozole

Abstract TC-01: Baby-TAM Impact on disease progression

Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Could immunotherapy offer potential in managing bacterial dysbiosis in prostate cancer

Long‐term prediction by DNA methylation of high‐grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort

Body composition changes during breast cancer preventive treatment with anastrozole: Findings from the IBIS-II trial

Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States

Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the …

Jack Cuzick Information

University

Position

___

Citations(all)

129759

Citations(since 2020)

36221

Cited By

104398

hIndex(all)

158

hIndex(since 2020)

88

i10Index(all)

623

i10Index(since 2020)

391

Email

University Profile Page

Google Scholar

Jack Cuzick Skills & Research Interests

cancer prevention

Top articles of Jack Cuzick

Abstract PS10-03: Impact of Baseline Oestradiol and Testosterone on the Preventive Effect of Anastrozole

Cancer Research

2024/5/2

Jack Cuzick
Jack Cuzick

H-Index: 89

Abstract TC-01: Baby-TAM Impact on disease progression

Cancer Research

2024/5/2

Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Cancer Epidemiology, Biomarkers & Prevention

2024/4/26

Could immunotherapy offer potential in managing bacterial dysbiosis in prostate cancer

Cancer Research

2024/3/22

Long‐term prediction by DNA methylation of high‐grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort

International Journal of Cancer

2024/3/20

Body composition changes during breast cancer preventive treatment with anastrozole: Findings from the IBIS-II trial

Preventive Medicine Reports

2024/2/1

Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States

American Journal of Obstetrics and Gynecology

2024/2/1

Michael Robertson
Michael Robertson

H-Index: 5

Jack Cuzick
Jack Cuzick

H-Index: 89

Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the …

The Lancet Oncology

2024/1/1

Jack Cuzick
Jack Cuzick

H-Index: 89

The importance of long-term follow up of participants in clinical trials

2023/2/2

Jack Cuzick
Jack Cuzick

H-Index: 89

Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester

BMC Women's Health

2023/1/13

Computerized Quantification of Tumor Infiltrating Lymphocyte (TIL) as a prognostic and predictive factor in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial

2023

A case–control study to evaluate the impact of the breast screening programme on breast cancer incidence in England

Cancer Medicine

2023/1

Jack Cuzick
Jack Cuzick

H-Index: 89

Peter Sasieni
Peter Sasieni

H-Index: 43

An optimization framework to guide the choice of thresholds for risk-based cancer screening

NPJ Digital Medicine

2023/11/28

Celeste Damiani
Celeste Damiani

H-Index: 3

Jack Cuzick
Jack Cuzick

H-Index: 89

Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study

Breast Cancer Research

2023/11/24

Jack Cuzick
Jack Cuzick

H-Index: 89

Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent

Genetics in Medicine

2023/9/1

Jack Cuzick
Jack Cuzick

H-Index: 89

Gad Rennert
Gad Rennert

H-Index: 53

A mediation analysis of obesity and adiponectin association with postmenopausal breast cancer risk: a nested cohort study in the IBIS-II Prevention Trial

2023/7/12

Jack Cuzick
Jack Cuzick

H-Index: 89

Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States

International Journal of Cancer

2023/7/1

Jack Cuzick
Jack Cuzick

H-Index: 89

Michael Robertson
Michael Robertson

H-Index: 5

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised …

British journal of cancer

2023/6/15

Evaluation of an AI model to assess future breast cancer risk

Radiology

2023/6/13

Celeste Damiani
Celeste Damiani

H-Index: 3

Jack Cuzick
Jack Cuzick

H-Index: 89

See List of Professors in Jack Cuzick University(Queen Mary University of London)